Smart Pills Help Monitor Cancer Patients’ Therapy
Smart Pills Help Monitor Cancer Patients’ Therapy
Sensors encapsulated with oral chemotherapy drugs help patients and physicians keep track of treatments.
Smart Pills Help Monitor Cancer Patients’ Therapy
Smart Pills Help Monitor Cancer Patients’ Therapy

Sensors encapsulated with oral chemotherapy drugs help patients and physicians keep track of treatments.

Sensors encapsulated with oral chemotherapy drugs help patients and physicians keep track of treatments.

oncology
Mardis on the Future of Clinical Genomics
Mardis on the Future of Clinical Genomics
The Scientist Staff | Jul 15, 2019
Meet researcher Elaine Mardis of the Institute for Genomic Medicine at Nationwide Children’s Hospital in Ohio and coauthor of a feature article on cancer vaccines.
Tumor Organoids Hold Promise for Personalizing Cancer Therapy
Tumor Organoids Hold Promise for Personalizing Cancer Therapy
Jef Akst | Jul 15, 2019
The three-dimensional cell cultures are still in the development phase, but researchers are excited about their use to predict patients’ responses to various treatment options.
Cancer Leader LaSalle Leffall, Jr. Dies
Cancer Leader LaSalle Leffall, Jr. Dies
Ashley Yeager | May 30, 2019
The Howard University surgeon was the first African American president of the American Cancer Society and mentored thousands of medical students.
Found: A Cancer Drug’s Mechanism of Action
Found: A Cancer Drug’s Mechanism of Action
Ashley P. Taylor | May 21, 2019
As ONC201 moves through human clinical trials, scientists finally figure out that the compound and its analogs target a mitochondrial protease.
AI Uses Images and Omics to Decode Cancer
AI Uses Images and Omics to Decode Cancer
Amber Dance | May 1, 2019
Machine learning can analyze photographs of cancer, tumor pathology slides, and genomes. Now, scientists are poised to integrate that information into cancer uber-models.
A Revised CAR T for Lymphoma Has Fewer Side Effects
A Revised CAR T for Lymphoma Has Fewer Side Effects
Kerry Grens | Apr 23, 2019
An early-stage clinical study finds that none of the 25 patients treated developed neurotoxicity or cytokine release syndrome, common hazards of the cancer immunotherapy.
Q&A: Epigenetic Therapies for Breast Cancer
Q&A: Epigenetic Therapies for Breast Cancer
Katarina Zimmer | Apr 4, 2019
Breast cancer researcher and oncologist Nancy Davidson discusses what we’ve learned from the first wave of epigenetic trials for breast cancer, and what challenges lie ahead before such therapies reach the clinic.
Contending with Resistance in Cancer Immunotherapy
Contending with Resistance in Cancer Immunotherapy
Marissa Fessenden | Apr 1, 2019
Researchers describe ways to study how cancer cells evade therapies that harness the immune system.
Cancer-Specific Antigens Encoded in “Junk” DNA
Cancer-Specific Antigens Encoded in “Junk” DNA
Carolyn Wilke | Apr 1, 2019
Researchers found that allegedly noncoding genetic material carries the instructions for many peptides that may help harness the immune system to fight cancer.